 产品搜索 |
| 产品类别 |
| 推荐产品 |
 叔丁基二甲基氯硅烷 |
| 2-氯-4,6-二甲基吡啶 |
| 2-溴-4,6-二甲基吡啶 |
| 6-氯苯并三氮唑-1,1,3,3- |
| 1,3-二苯基异苯并呋喃 |
| 培哚普利 |
| 9-(4-乙酰氧基-3-乙酰氧 |
| 嘧啶-5-硼酸 |
| 2-氯-3-硝基-4-甲基吡啶 |
| 7-氮杂吲哚 |
| 4-氮杂吲哚 |
| 5-氮杂吲哚 |
| 6-氮杂吲哚 |
| 7-azaoxindole |
| 6-azaoxindole |
| 4-叔丁基苯硼酸 |
| D-氨基半乳糖盐酸盐 |
| N-乙酰基-D-氨基半乳糖 |
| 溴代葡萄糖苷 |
| 利培酮 |
| N-三氟乙酰基-L-赖氨酸 |
| N2-(1-乙氧羰基-3-苯丙基 |
| N2-[1-(S)-乙氧羰基-3-苯 |
| 3-氨基甲酰基苯硼酸 |
| 2,4-二氯-6-甲基嘧啶 |
| N-(4-氨基丁基)-N-乙基异 |
| AOP |
| BOP |
| 4,4-二甲氧基三苯甲基 |
| 2-氯-1-甲基吡啶碘盐 |
| HOTT |
| TSTU |
| 1-(4-甲磺基)-3-硝基-1,2,4 |
| TPTU |
| 2,4,6-三异丙基苯磺酰氯 |
| TOTU |
| TOTT |
| TNTU |
| TFFH |
| TDBTU |
| TCTU |
| TCFH |
| TBTU |
| TATU |
| N-Hydroxysulfosuccinimide sodi |
| 8-喹啉磺酰氯 |
| PyCloP |
| PYCLU |
| PyBroP |
| PyBOP |
|
| 产品展示 |
| 产品编号 |
产品名称 |
CAS No. |
含量 |
| W749561 | 1,6-dihydro-N-((4-(methoxymethyl)phenyl)(4-methoxyphenyl)methyl)-6-oxo-2-(pyridazin-3-yl)pyrimidine-5-carboxamide | 1187992-78-4 | 95% |
| W749562 | 1,6-dihydro-N-[(4-methoxyphenyl)(6-methoxy-3-pyridinyl)methyl]-6-oxo-2-(3-pyridazinyl)-5-Pyrimidinecarboxamide | 1187992-67-1 | 95% |
| W749563 | N-[(6-chloro-3-pyridinyl)(4-methoxyphenyl)methyl]-1,6-dihydro-6-oxo-2-(3-pyridazinyl)-5-Pyrimidinecarboxamide | 1187992-65-9 | 95% |
| W749564 | (2,4-dimethoxyphenyl)(6-methyl-2-pyridinyl)Methanone | 1187163-23-0 | 95% |
| W749565 | 4-bromo-2-Pyridinecarboximidamide hydrochloride | 1179360-58-7 | 95% |
| W749566 | bis(4-(methoxymethyl)phenyl)methanamine | 170689-12-0 | 95% |
| W749567 | 6-(nitromethyl)-1,4-Dioxepan-6-ol | 1509909-27-6 | 95% |
| W749568 | 4-bromo-5-methyl-1-[(tetrahydro-2H-pyran-2-yl)methyl]-1H-Pyrazole | 1449564-61-7 | 95% |
| W749569 | 1-[[1-(2-methoxyethyl)cycloheptyl]methyl]-5-methyl-1H-Pyrazole | 1449564-57-1 | 95% |
| W749570 | 4-[2-[2-[(4-iodo-5-methyl-1H-pyrazol-1-yl)methyl]phenoxy]ethyl]Morpholine | 1449564-47-9 | 95% |
| W749571 | 1-(phenylsulfonyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-Pyrrole | 1430754-38-3 | 95% |
| W749572 | 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-Pyrazole-3-carbonitrile | 1430754-35-0 | 95% |
| W749573 | 1-benzyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-c]pyridine | 1430754-31-6 | 95% |
| W749574 | 1-benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole | 1430754-29-2 | 95% |
| W749575 | 5-methyl-1-[(tetrahydro-2,6,6-trimethyl-2H-pyran-2-yl)methyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-Pyrazole | 1430754-27-0 | 95% |
| W749576 | 4-bromo-5-methyl-1-[(tetrahydro-2,6,6-trimethyl-2H-pyran-2-yl)methyl]-1H-Pyrazole | 1430754-26-9 | 95% |
| W749577 | 5-methyl-1-[(tetrahydro-2,6,6-trimethyl-2H-pyran-2-yl)methyl]-1H-Pyrazole | 1430754-25-8 | 95% |
| W749578 | 6-methyl-2-((5-methyl-1H-pyrazol-1-yl)methyl)hept-5-en-2-ol | 1430754-24-7 | 95% |
| W749579 | N-[2-[[1-[(4-bromo-5-methyl-1H-pyrazol-1-yl)methyl]-3,3-dimethylcyclohexyl]oxy]ethyl]-N-methylCarbamic acid 2-(trimethylsilyl)ethyl ester | 1430754-23-6 | 95% |
| W749580 | 4-bromo-1-(1-cyclohexyl-3-methoxypropyl)-5-methyl-1H-Pyrazole | 1430754-21-4 | 95% |
| W749581 | 1-(1-cyclohexyl-3-methoxypropyl)-5-methyl-1H-Pyrazole | 1430754-20-3 | 95% |
| W749582 | 1-(1-cyclohexyl-3-methoxypropyl)-1H-Pyrazole | 1430754-19-0 | 95% |
| W749583 | 3-cyclohexyl-3-(1H-pyrazol-1-yl)propan-1-ol | 1430754-18-9 | 95% |
| W749584 | N-(3-bromo-2-cyanophenyl)-N-methylCyclohexanesulfonamide | 1430754-13-4 | 95% |
| W749585 | 1-[[1-(2-methoxyethoxy)-3,3-dimethylcyclohexyl]methyl]-5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-Pyrazole | 1430754-12-3 | 95% |
| W749586 | 4-bromo-1-[[1-(2-methoxyethoxy)-3,3-dimethylcyclohexyl]methyl]-5-methyl-1H-Pyrazole | 1430754-11-2 | 95% |
| W749587 | 2-[[1-[(4-bromo-5-methyl-1H-pyrazol-1-yl)methyl]-3,3-dimethylcyclohexyl]oxy]Ethanol | 1430754-10-1 | 95% |
| W749588 | 4-bromo-1-[[3,3-dimethyl-1-(2-propen-1-yloxy)cyclohexyl]methyl]-5-methyl-1H-Pyrazole | 1430754-09-8 | 95% |
| W749589 | N-(3-bromo-2-methylphenyl)-N,1-dimethylCyclohexanecarboxamide | 1430754-07-6 | 95% |
| W749590 | 4-bromo-1-[[3,3-dimethyl-1-[2-(methylsulfonyl)ethoxy]cyclohexyl]methyl]-5-methyl-1H-Pyrazole | 1430754-05-4 | 95% |
|
|
|
|
